Sign In
Buy AMT
$166.06
+2.67 (+1.63%)
At Close: Jul 22, 2026
uniQure's AMT-130 Gene Therapy Warrants An Upgrade
04:56am, Wednesday, 28'th May 2025
uniQure recently divested from its Lexington facility to Genezen and freed $25 million while significantly reducing its operating costs. At the same time, AMT-130 has received the FDA's Breakthrough T
REITs: The Riches Are In The Niches
07:00am, Sunday, 25'th May 2025
REITs offer diversified, inflation-hedged income and capital appreciation, making them a compelling addition to any long-term investment portfolio. Current REIT valuations are attractive, with strong
American Tower Corporation Prices Senior Notes Offering
04:15pm, Wednesday, 21'st May 2025
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today announced the pricing of its registered public offering of senior unsecured notes due 2032 in an aggregate principal amount of €
American Tower Stock Up 11.8% in 3 Months: Will It Rise Further?
01:41pm, Tuesday, 20'th May 2025
AMT to gain from increased investments by wireless carriers in 4G and 5G networks. Solid business fundamentals and strategic capital allocation are add-ons.
Tariffs Up, Inflation Down
09:00am, Sunday, 18'th May 2025
US equity markets surged this week - extending a dramatic post "Liberation Day" rebound - after the White House announced a trade truce with China, while investors cheered surprisingly cool inflation
2 Infrastructure-Focused CEFs Delivering Monthly Distributions
02:16pm, Friday, 16'th May 2025
Infrastructure is essential to everyday life for most of civilization, which can provide stability and predictable cash flows. We are looking at two different closed-end funds that provide diversified
American Tower Corporation Declares Quarterly Distribution
04:15pm, Thursday, 15'th May 2025
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) announced that its Board of Directors has declared a quarterly cash distribution of $1.70 per share on shares of the Company's common st
American Tower Corporation (AMT) Annual JPMorgan Global Technology, Media and Communications Conference (Transcript)
02:40pm, Tuesday, 13'th May 2025
American Tower Corporation (NYSE:AMT ) Annual JPMorgan Global Technology, Media and Communications Conference May 13, 2025 10:50 AM ET Company Participants Steve Vondran - President and CEO Conference
Nokia selected by CoreSite for routing-based network edge solution to support data-intensive, mission-critical applications
09:00am, Tuesday, 13'th May 2025
Press Release Nokia selected by CoreSite for routing-based network edge solution to support data-intensive, mission-critical applications CoreSite deploys Nokia IP routing portfolio across 30 data cen
Is it Wise to Retain American Tower Stock in Your Portfolio Now?
02:16pm, Monday, 12'th May 2025
AMT is likely to gain from the solid demand for wireless connectivity and capital allocation strategy despite customer concentration and consolidation.
Trade Talks, Fed Hawks, Market Balks
09:00am, Sunday, 11'th May 2025
US equity markets posted modest declines this past week after the Federal Reserve held rates steady and maintained its status quo "wait-and-see" approach, but acknowledged heightened inflation and lab
American Tower's Quiet Phase May Be Ending - Why It Still Has Legs To Run
07:36am, Saturday, 10'th May 2025
American Tower benefits from strong secular trends in mobile data demand, 5G infrastructure expansion, and edge computing, driving robust top-and-bottom-line results. Despite recent sluggish stock per
Scale Has Its Advantages: 3 A-Rated REIT Monopolies
07:00am, Saturday, 10'th May 2025
Scale is a critical competitive advantage for companies, enabling them to expand, attract capital, and achieve strong market positions, as seen with Realty Income, Prologis, and Public Storage. Realty
American Tower: Doubling Down On Its Data Center Ambitions - Maintain Buy
09:41am, Friday, 09'th May 2025
AMT continues to benefit from its vertically integrated telecom and data center/interconnection capabilities, as it delivers excellent top/bottom-line growth ahead. The same has been observed in its r
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
07:05am, Friday, 09'th May 2025
~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related
